What happens when you take hibiscus tea with hydrochlorothiazide?
Hibiscus tea is brewed from the dried calyces of Hibiscus sabdariffa, known regionally as roselle, sorrel, agua de Jamaica, karkade, or bissap. It is a popular cardiovascular tonic with a long history of traditional use for high blood pressure, and modern randomized trials confirm that daily consumption of two to three cups can lower systolic blood pressure by roughly 5 to 10 mmHg in adults with mild hypertension.
Hydrochlorothiazide (HCTZ) is a thiazide diuretic prescribed for hypertension and edema. It works on the distal convoluted tubule of the kidney, blocking the sodium-chloride symporter so that more sodium and water are excreted, with consequent loss of potassium and magnesium.
The interaction between hibiscus and HCTZ has two components. First, there is a pharmacodynamic overlap: both substances lower blood pressure and act as diuretics, so co-administration produces an additive effect. Second, a controlled animal study by Ndhlala and colleagues demonstrated a pharmacokinetic interaction. Co-administering hibiscus extract with HCTZ in rats significantly increased the area under the plasma concentration-time curve of HCTZ and reduced its renal clearance, effectively raising the systemic exposure to the drug. Human data are still limited, but the animal evidence is consistent and biologically plausible.
Why is this important?
For some patients, the additive blood pressure effect is welcome: hibiscus is sometimes recommended as a complement to standard antihypertensive therapy. The problem is that the effect is not always predictable, and several real-world risks come with it.
The first risk is symptomatic hypotension. Older patients, those on multiple antihypertensives (an ACE inhibitor or ARB plus HCTZ plus a calcium channel blocker is a common regimen), or anyone who is already running on the lower edge of their target blood pressure can develop dizziness, lightheadedness on standing, falls, or fatigue when daily hibiscus is added.
The second risk is electrolyte disturbance. HCTZ already causes potassium and magnesium wasting. Hibiscus adds further diuretic effect and may itself contribute to potassium loss, raising the chance of hypokalemia. Low potassium can cause muscle cramps, weakness, palpitations, and in severe cases dangerous cardiac arrhythmias, particularly in patients who are also on digoxin or QT-prolonging drugs.
The third risk is the increased HCTZ exposure suggested by the animal pharmacokinetic data. Higher drug levels mean a higher likelihood of HCTZ's typical side effects: hyperuricemia and gout flares, hyperglycemia, mild dyslipidemia, hyponatremia, and increased photosensitivity.
What should you do?
If you are not yet on HCTZ but already drink hibiscus tea regularly, tell your prescriber before starting the medication. They may want to begin at a lower HCTZ dose and titrate based on response.
If you are already on HCTZ and considering adding hibiscus tea, the safest approach is to do so deliberately and slowly. Start with one cup a day rather than three or four. Check your blood pressure at home before and after starting, ideally with morning and evening readings for the first two weeks. Schedule a basic metabolic panel (electrolytes, kidney function) with your clinician within four weeks of beginning regular hibiscus consumption to confirm that potassium and sodium remain in range.
Avoid combining concentrated hibiscus extracts or capsules with HCTZ unless your clinician explicitly approves; standardized extracts can deliver many times more active compound than a single cup of tea.
Watch for warning signs that the combined effect has gone too far: dizziness or lightheadedness, particularly on standing; muscle cramps or weakness; palpitations; persistent fatigue; very dry mouth and reduced urine output (signs of dehydration); or repeated home blood pressure readings below 100/60 mmHg if you do not normally run low.
Which specific products are affected?
The interaction applies to all thiazide and thiazide-like diuretics, including hydrochlorothiazide (Microzide), chlorthalidone (Hygroton), indapamide (Lozol), and metolazone (Zaroxolyn). It is also relevant for combination antihypertensives containing HCTZ, such as lisinopril-HCTZ (Zestoretic), losartan-HCTZ (Hyzaar), valsartan-HCTZ (Diovan HCT), telmisartan-HCTZ (Micardis HCT), olmesartan-HCTZ (Benicar HCT), and triamterene-HCTZ (Dyazide, Maxzide).
On the hibiscus side, the interaction concern applies to brewed hibiscus tea (Hibiscus sabdariffa), agua de Jamaica, karkade, sorrel beverages, hibiscus blends in popular brands such as Tazo Passion or Celestial Seasonings Red Zinger, and concentrated hibiscus capsules or extracts sold for blood pressure support.
The bottom line
Hibiscus tea and hydrochlorothiazide both lower blood pressure and act as diuretics, and animal data suggest hibiscus also raises HCTZ blood levels. Together they can cause additive blood pressure lowering, dehydration, and low potassium. Occasional hibiscus tea is unlikely to cause problems, but daily consumption of multiple cups while on HCTZ warrants caution, home blood pressure monitoring, and a follow-up electrolyte check within a month of starting.